Q4 2017 Annual Press Conference, and Analysts Call

Our Q4/FY 2017 results have been published on March 8, 2018.

Type of Event

Conference Call

08 Mar 2018

From 07:00 to 15:00

We achieve targets for 2017 – dividend to increase

  • Healthcare and Life Science drive sales growth (+2.0%)
  • EBITDA pre (–1.7%) burdened by currency headwinds
  • Organic sales growth in all regions
  • Progress made in reducing net financial debt
  • Dividend proposal € 1.25 (+€ 0.05)

We are staying the course

“2017 was a good year for our company. We performed well in a challenging environment and met all ourtargets for  the year. We are staying the course and will continue to purposefully implement our innovation-driven growth strategies for Healthcare, Life Science and Performance Materials. In addition, we are resolutely working to quickly lower our acquisition-related debt-to-equity ratio.”

(Stefan Oschmann, CEO and Chairman of the Executive Board)

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Achieves Targets for 2017 – Dividend to Increase

    Merck KGaA, Darmstadt, Germany met its targets for 2017 and achieved important strategic successes with the approvals of two new medicines.


Markus Talanow

Financial Communications

+49 6151 72-7144

+49 6151 72-3138

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271